Data for the modeling of drug-receptor interaction, taking into consideration additives or combined active ingredients in the formulation
Bozzay, J.; Békefi, E.; Dávid, A.; Rusznák, I.
Acta Pharmaceutica Hungarica 53(3): 97-105
1983
ISSN/ISBN: 0001-6659 PMID: 6880768 Document Number: 216176
Document emailed within 1 workday
Related Documents
Selmeczi, B.; Kedvessy, G.; Nagy, G.; Pintyéné Hódi, K.; Tencova, A.; Kiszeleva, G. 1981: Influence of the technological procedure and additives on the dissolution rate and absorption of active ingredients. I. Physical properties of acetylsalicylic acid tablets and of the dissolution rate of the active ingredient Acta Pharmaceutica Hungarica 51(5): 222-227Trujillo-de Santiago, G.; Patricio Sáenz-Collins, C.; García-Arellano, L.; Moisés Álvarez, M. 2014: Mathematical modeling of the release of active ingredients from a contraceptive patch: ortho evra(®) as a case study Iranian Journal of Pharmaceutical Research: Ijpr 13(1): 39-48
Rong, S.B.; Zhu, Y.C.; Jiang, H.L.; Zhao, S.R.; Wang, Q.M.; Chi, Z.Q.; Chen, K.X.; Ji, R.Y. 1997: Molecular modeling of mu opioid receptor and receptor-ligand interaction Zhongguo Yao Li Xue Bao 18(4): 317-322
Zhou, H.-f.; He, Y.; Zhang, Y.-y.; Yang, J.-h.; Zhao, T.; Fu, W.; Zhou, P.; Wan, H.-t. 2014: Protective effect of combined administration of active ingredients of Danhong on cerebral micro-vascular endothelial cell injured by hypoxia Zhongguo Zhong Yao Za Zhi 39(22): 4399-4404
Rong, S.B.; Jiang, H.L.; Chi, Z.Q.; Chen, K.X.; Zhu, Y.C.; Ji, R.Y. 1997: Molecular modeling of interaction between delta opioid receptor and 3-methylfentanylisothiocyanate Zhongguo Yao Li Xue Bao 18(3): 219-224
Pinheiro, E.D.S.; Antunes, O.A.C.; Fortunak, J.M.D. 2008: A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations Antiviral Research 79(3): 143-165
Krueger, G.R.; Koch, B.; Weldner, J.D.; Tymister, G.; Ramon, A.; Brandt, M.E.; Wang, G.; Buja, L.M. 2001: Dynamics of active progressive infection with HIV1: data acquisition for computer modeling In Vivo 15(6): 513-518
George, N.; Sujatha, C.H.; Kalyanasundaram, M. 1987: Controlled release formulation of mosquito larvicide with biodegradable ingredients Indian Journal of Medical Research 86: 728-732
Malik, A.; Mehmood, M.H.; Akhtar, M.S.; Haider, G.; Gilani, A.H. 2017: Studies on antihyperlipidemic and endothelium modulatory activities of polyherbal formulation (POL4) and its ingredients in high fat diet-fed rats Pakistan Journal of Pharmaceutical Sciences 30(1 Suppl): 295-301
Zin'kovskiĭ, V.G.; Golovenko, N.I.; Zhuk, O.V. 1988: Effector modeling of the effect of ligands of GABA receptor complex. Modification of conformation states of the complex by combined administration of benzodiazepines and barbiturates Biulleten' Eksperimental'noi Biologii i Meditsiny 106(10): 451-452
Carrier, G.O.; Matheny, J.L.; Ahlquist, R.P. 1975: Adrenergic drug-receptor interaction in the presence of strontium (Sr++) in mammalian myocardium Archives Internationales de Pharmacodynamie et de Therapie 218(1): 11-18
Sharma, M.; Legesse, H. 2016: Parametric Modeling of Survival Data Based on Human Immune Virus (HIV) Infected Adult Patients under Highly Active Antiretroviral Therapy (HAART): a Case of Zewditu Referral Hospital, Addis Ababa (AA), Ethiopia International Journal of Statistics in Medical Research 5(4): 240-247
Stampf 1978: In vitro studies on the interactions between active ingredients and adjuvants Die Pharmazie 33(7): 447-450
Chen, J.; Yang, C.-j.; Guo, Y.-h. 2007: Studies on accumulation of active ingredients, N, P and K in Anemarrhena asphodeloides Zhongguo Zhong Yao Za Zhi 32(15): 1504-1507
Loranskaia, T.I. 1997: Biologically active food additives and their use in internal medicine Klinicheskaia Meditsina 75(7): 18-21
Wang, S.F.; Zhan, S.Y. 2016: Active surveillance of adverse drug reaction in the era of big data: challenge and opportunity for control selection Zhonghua Liu Xing Bing Xue Za Zhi 37(7): 909-916
Geiger, C.M.; Sorenson, B.; Whaley, P. 2015: Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF International Journal of Pharmaceutical Compounding 19(5): 420-427
Yang, Y.; Yin, G.K. 1988: Diffuse reflectance studies on the interaction of ascorbic acid and tablet additives Yao Xue Xue Bao 23(2): 152-158
Sato, N.; Suzuki, H.; Hayashi, H.; Shibasaki, S.; Sugano, T.; Maebashi, K.; Kurosawa, T.; Shiomi, M.; Ogata, H. 2008: New concept and a theoretical consideration of the mechanism-based pharmacokinetics/ pharmacodynamics (PK/PD) modeling for antimicrobial agents Japanese Journal of Antibiotics 61(5): 314-338
Trischler, F.; Körmendy, G. 1979: Selective determination of the content of active ingredients in Lycurim by quaternary reaction Acta Pharmaceutica Hungarica 49(1): 9-12